High-grade B-cell lymphoma with MYC and BCL2 rearrangements presenting as a cervical mass

被引：1
|
作者：
Lin, Chiao [1 ]
Kuma, Leslie [1 ]
Shen, Linda [2 ]
机构：
[1] Townsville Univ Hosp, Dept Anat Pathol, Pathol Queensland, Townsville, Qld, Australia
[2] Princess Alexandra Hosp, Dept Anat Pathol, Pathol Queensland, Brisbane, Qld, Australia
来源：
PATHOLOGY | 2024年 / 56卷 / 04期
关键词：
D O I：
10.1016/j.pathol.2023.08.012
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：588 / 590
页数：3
相关论文
共 50 条
  • [21] Approach to the diagnosis and treatment of high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements
    Sesques, Pierre
    Johnson, Nathalie A.
    BLOOD, 2017, 129 (03) : 280 - 288
  • [22] Terminal deoxynucleotidyl transferase-positive high-grade B-cell lymphoma with MYC and BCL2 rearrangements transformed from follicular lymphoma
    Chiriac, Radu
    Baseggio, Lucile
    Donzel, Marie
    EJHAEM, 2024,
  • [23] High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: Biopsy analysis of 70 cases from the Slovak Lymphoma Registry
    Leskova, Katarina
    Szepe, Peter
    Balharek, Tomas
    Barthova, Martina
    Janakova, Luboslava
    Farkasova, Anna
    Plank, Lukas
    NEOPLASMA, 2022, 69 (04) : 957 - 964
  • [24] High-grade B-cell Lymphoma with MYC and BCL2 Rearrangement Arising from Follicular Lymphoma: Presentation as a Large Peripancreatic Mass
    Shestakova, Anna
    Rezk, Sherif
    Ghasemizadeh, Dara
    Nael, Ali
    Zhao, Xiaohui
    DIAGNOSTICS, 2020, 10 (03)
  • [25] Gemcitabine, Dexamethasone, and Cisplatin Regimen as an Effective Salvage Therapy for High-grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements
    Mitobe, Masaki
    Kawamoto, Keisuke
    Suzuki, Takaharu
    Kiryu, Maiko
    Tamura, Suguru
    Nanba, Ayako
    Suwabe, Tatsuya
    Tanaka, Tomoyuki
    Fuse, Kyoko
    Shibasaki, Yasuhiko
    Masuko, Masayoshi
    Miyoshi, Hiroaki
    Ohshima, Koichi
    Sone, Hirohito
    Takizawa, Jun
    INTERNAL MEDICINE, 2019, 58 (04) : 575 - 580
  • [26] Molecular characterization of a rare case of high-grade B-cell lymphoma with MYC, BCL2, BCL6, and CCND1 rearrangements
    Monika, Fnu
    Sabri, Ahmed
    Cantu, David
    Vail, Eric
    Siref, Andrew
    JOURNAL OF HEMATOPATHOLOGY, 2024, 17 (03) : 155 - 161
  • [27] Mediastinal B-cell lymphoma with MYC, BCL2, and BCL6 rearrangements
    Ocal, Jon L.
    Feldman, Andrew L.
    Greipp, Patricia T.
    Rimsza, Lisa M.
    JOURNAL OF HEMATOPATHOLOGY, 2022, 15 (03) : 151 - 155
  • [28] Mediastinal B-cell lymphoma with MYC, BCL2, and BCL6 rearrangements
    Jon L. Ocal
    Andrew L. Feldman
    Patricia T. Greipp
    Lisa M. Rimsza
    Journal of Hematopathology, 2022, 15 : 151 - 155
  • [29] Clinicopathological and genomic analysis of double-hit follicular lymphoma: comparison with high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements
    Miyaoka, Masashi
    Kikuti, Yara Y.
    Carreras, Joaquim
    Ikoma, Haruka
    Hiraiwa, Shinichiro
    Ichiki, Akifumi
    Kojima, Minoru
    Ando, Kiyoshi
    Yokose, Tomoyuki
    Sakai, Rika
    Hoshikawa, Masahiro
    Tomita, Naoto
    Miura, Ikuo
    Takata, Katsuyoshi
    Yoshino, Tadashi
    Takizawa, Jun
    Bea, Silvia
    Campo, Elias
    Nakamura, Naoya
    MODERN PATHOLOGY, 2018, 31 (02) : 313 - 326
  • [30] EBV-positive low-grade follicular lymphoma transforming to EBV-negative high-grade B-cell lymphoma with MYC and BCL2 rearrangements
    Nam, Mann Hua
    Hsieh, Yao-Yu
    Chen, Bo-Jung
    PATHOLOGY, 2022, 54 (05) : 634 - 636
12345